Storia in 5 fonti

LSD's Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors

News and commentary from the psychiatry world

Raccontata da

Confronto fonti

5 prospettive sulla stessa storia

AI · summaries

medpagetoday.comStai leggendo1 g fa

LSD's Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors

News and commentary from the psychiatry world

originale

statnews.com3 g fa

Definium LSD therapy helped patients with major depression in late-stage trial

Definium Therapeutics said that its LSD therapy helped patients with major depression in its first Phase 3 trial, bringing the psychedelic drug closer to a potential approval.

Leggi questa versione → originale

gizmodo.com2 g fa

LSD Just Passed Its Biggest Test Yet for Treating Depression

Definium Therapeutics annuncia Phase III di DT120 (LSD proprietaria): singola dose raggiunge 35% remissione versus 7% placebo nella depressione clinica. Per manager tech il segnale è una terapia single-dose disruptive rispetto ai trattamenti cronici attuali, con impatto potenziale su employee wellness e healthcare spending aziendale.

Leggi questa versione → originale

endpoints.news3 g fa

Definium reports Phase 3 hit for LSD drug in severe form of depression

Definium's LSD drug DT120 hit its Phase 3 MDD primary endpoint, beating analyst expectations with significant improvement in depression symptoms.

Leggi questa versione → originale

zerohedge.com2 g fa

Definium Soars As Much As 50% After LSD-Based Depression Drug Meets Late-Stage Clinical Trial Goal

DT120, a psychedelic that activates serotonin receptors, was generally well tolerated, with mostly mild side effects occurring on dosing day and no serious safety concerns.

Leggi questa versione → originale

Timeline cronologica

lunedì 22 giugno 2026·statnews.com
Definium LSD therapy helped patients with major depression in late-stage trial
Definium Therapeutics said that its LSD therapy helped patients with major depression in its first Phase 3 trial, bringing the psychedelic drug closer to a potential approval.
lunedì 22 giugno 2026·endpoints.news
Definium reports Phase 3 hit for LSD drug in severe form of depression
Definium's LSD drug DT120 hit its Phase 3 MDD primary endpoint, beating analyst expectations with significant improvement in depression symptoms.
lunedì 22 giugno 2026·zerohedge.com
Definium Soars As Much As 50% After LSD-Based Depression Drug Meets Late-Stage Clinical Trial Goal
DT120, a psychedelic that activates serotonin receptors, was generally well tolerated, with mostly mild side effects occurring on dosing day and no serious safety concerns.
lunedì 22 giugno 2026·gizmodo.com
LSD Just Passed Its Biggest Test Yet for Treating Depression
People taking Definium Therapeutics' DT120 showed long-lasting reductions in their depression symptoms compared to a placebo, the company announced Monday.
mercoledì 24 giugno 2026·medpagetoday.com
LSD's Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors
News and commentary from the psychiatry world